Cargando…
SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells
The downregulation of SPRED2, a negative regulator of the ERK1/2 pathway, was previously detected in human cancers; however, the biological consequence remains unknown. Here, we investigated the effects of SPRED2 loss on hepatocellular carcinoma (HCC) cell function. Human HCC cell lines, expressing...
Autores principales: | Gao, Tong, Yang, Xu, Fujisawa, Masayoshi, Ohara, Toshiaki, Wang, Tianyi, Tomonobu, Nahoko, Sakaguchi, Masakiyo, Yoshimura, Teizo, Matsukawa, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003366/ https://www.ncbi.nlm.nih.gov/pubmed/36902429 http://dx.doi.org/10.3390/ijms24054996 |
Ejemplares similares
-
Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice
por: Ohkura, Takahiro, et al.
Publicado: (2019) -
Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder
por: Oda, Shinsuke, et al.
Publicado: (2021) -
A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation
por: Takahashi, Sakuma, et al.
Publicado: (2016) -
Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα
por: Yang, Xu, et al.
Publicado: (2018) -
Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4(+) and CD8(+) T cells
por: Sun, Cuiming, et al.
Publicado: (2021)